Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...
  • 9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...
  • 9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...
  • 9/8/2025Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...
  • 9/5/2025Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...
  • 9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval
  • 9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102
  • 9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...
  • 9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development
  • 9/4/2025iRegene Raises Series B+ to Advance Parkinson's and Ophthalmology Cell...
  • 9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...
  • 9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...
  • 9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
  • 9/3/2025China to Become World's Third-Largest Innovative Drug Market by 2028:...
  • 9/3/2025E-nitiate Biopharma Secures ~¥200M in Series B Funding to Advance Au...
  • 9/3/2025Sanofi China Receives Approval for Tzield to Delay Progression of Type...
  • 9/3/2025Argo Biopharma Strikes $5.2B Cardiovascular Collaboration with Novarti...
  • 9/3/2025China Biopharma Sees $320M Upfronts and $8.5B Milestones in H1 2025 Li...
  • 9/3/2025Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...
  • 9/2/2025Astellas Accelerates Growth and Innovation in China
  • 9/2/2025Nine First-in-Class Drugs Receive Initial Clinical Approval in China
  • 9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
  • 9/2/2025China Approved Seven New Drugs in August
  • 9/1/2025BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...
  • 9/1/2025Fosun Licenses Accro's TYK2/JAK1 Inhibitor AC-201 in Greater China
  • 9/1/2025Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...
  • 9/1/2025Ennovabio Secures New Financing to Advance Pipeline for Immune and Met...
  • 9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
  • 9/1/2025Convalife's HKEX IPO Application Gets Green Light
  • 9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
  • Page:9/58 Total number of articles:1740: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group